Sequential polychemotherapy in exocrine pancreatic cancer

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 841-844

  Klapdor, R ^a,b   Bahlo, M ^b   Babinski, A ^b   Broemel, T ^c   Muller C ^d   Seutter, R ^e  

^a Jerusalem Hospital   (Germany)

^b ZeTDT GmbH   (Germany)

^c Radiology Units   (Germany)

^d Eppendorf University   (Germany)

^e Damtor   (Germany)

Author keywords

Exocrine; Pancreatic cancer; Sequential polychemotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; FLOXANTINE R; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; OXALIPLATIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037861975     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Klabdor R, Scutter E, Lang-Polckow EM, Reichle H and Hinrichs A; Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of Mitomycin-C and Gemcitabine and simultaneous follow-up by imaging methods and tumor markers. Anticancer Res 19: 2469-2470, 1999.
2. Klapdor R (für die Arbeitsgruppe): Arbeitsgruppe Qualitätskontrolle und Standardiscerung von Tumormarkertests. in Rahmen der Hanburger Symposien tiber Tumormarker. Tumordiagn Ther 13: xix-xxii, 1992.
3. EGTM-Concensus Recommendations. Anticancer Res 19: 2785-2820, 1999.